Scott Powell | EVP, IR |
Cameron Reynolds | President & CEO |
Mark Breidenbach | Oppenheimer |
Jason McCarthy | Maxim Group |
Bruce Jackson | The Benchmark Company |
Brian Marckx | Zacks Investment Research |
Good morning ladies and gentlemen. Thank you for standing by. Welcome to VolitionRx Limited Fourth Quarter and Full Fiscal Year 2018 Earnings Conference Call.
During today’s presentation, all parties will be in a listen-only mode.
Following the presentation, the conference call will be open for questions.